Fluid Physiology & the Three Questions
"Fluid is a drug, with a dose, a therapeutic window and toxicity. Too little leaves the patient hypovolaemic and hypoperfused; too much causes tissue oedema, impaired wound and anastomotic healing, ileus and respiratory failure. The evidence has moved away from both the old 'liberal' regimens and extreme restriction, toward a zero-balance, individualised approach guided by the patient's actual physiology."
Synthesised from Miller's Anesthesia, 9th Ed โ Perioperative Fluid & Electrolyte Therapy.- Maintenance โ replacing normal ongoing losses in a fasting patient (water, Naโบ, Kโบ, glucose). The "4-2-1 rule" gives an hourly rate (4 mL/kg for first 10 kg + 2 for next 10 + 1 for each kg thereafter).
- Replacement โ correcting existing deficits (fasting, vomiting, bleeding, third-space/evaporative surgical losses).
- Resuscitation โ restoring circulating volume in shock: small, repeated boluses guided by response, not a fixed large volume.
Isotonic crystalloid distributes across the whole extracellular space, so only ~โ (or less) stays intravascular โ you need roughly 3โ4 mL of crystalloid per 1 mL of blood loss if using crystalloid alone. 5% dextrose distributes across total body water and is useless for resuscitation. Match the fluid to the compartment you are trying to fill.
Crystalloids vs Colloids & "Balanced" Solutions
"For most surgical patients a balanced crystalloid is the resuscitation fluid of choice. Large volumes of 0.9% saline produce a hyperchloraemic metabolic acidosis and are associated with more renal dysfunction than balanced solutions. Synthetic colloids โ the hydroxyethyl starches in particular โ have fallen out of favour after trials linked them to renal injury and increased mortality in the critically ill; albumin retains a limited role."
Synthesised from Barash โ Clinical Anesthesia; Morgan & Mikhail's Clinical Anesthesiology.| Fluid | Type | Key features | Caveats |
|---|---|---|---|
| Balanced crystalloid (Ringer's lactate / Plasma-Lyte / Hartmann's) | Crystalloid | Physiological Clโป, buffer (lactate/acetate) โ first choice for resuscitation & replacement | Lactate/Kโบ content โ caution in severe hyperkalaemia; avoid Hartmann's in the same line as blood (calcium) |
| 0.9% saline | Crystalloid | Clโป 154 โ useful in hypochloraemic alkalosis, TBI (Naโบ), hyponatraemia | Hyperchloraemic metabolic acidosis & AKI in large volumes |
| 5% dextrose | Crystalloid (free water) | Provides water & some glucose | Distributes to total body water โ not a resuscitation fluid |
| Human albumin (4โ5% / 20%) | Colloid | Role in some settings (e.g. large-volume paracentesis, selected sepsis) | Cost; avoid as routine; harmful in traumatic brain injury (SAFE) |
| Hydroxyethyl starch (HES) | Synthetic colloid | Volume expansion | Avoid in critically ill/sepsis โ AKI & mortality (6S, CHEST); restricted by regulators |
Colloids do not improve survival over crystalloids and cost more (SAFE trial: albumin โ saline overall, and worse in TBI). Balanced crystalloids are the default; reserve albumin for specific indications; avoid starches. In major surgery the aim is euvolaemia (zero fluid balance), not supranormal loading.
Component Therapy & When to Transfuse
- Packed red cells โ raise oxygen-carrying capacity; ~1 unit raises Hb by ~10 g/L in an adult.
- Fresh frozen plasma (FFP) โ clotting factors; ~12โ15 mL/kg for coagulopathic bleeding.
- Platelets โ for thrombocytopenia/dysfunction with bleeding; keep >50 ร10โน/L for surgery, >100 for neuro/eye/major.
- Cryoprecipitate / fibrinogen concentrate โ for hypofibrinogenaemia (keep fibrinogen >1.5โ2 g/L in obstetric/major haemorrhage).
โข Transfuse at Hb <70 g/L, target 70โ90 g/L, for most patients.
โข Hb <80 g/L threshold for symptomatic patients / acute coronary syndrome / chronic cardiovascular disease.
โข Transfuse a single unit and reassess (don't transfuse by a "two-unit" reflex).
Treat the cause of anaemia, and remember the trigger is a guide, not a substitute for assessing bleeding, symptoms and physiology.
Balanced crystalloids (Ringer's lactate) are the ubiquitous, economical default for perioperative fluid therapy. Pre-operative iron-deficiency anaemia is very common โ optimise with iron (oral/IV) in the PAC clinic rather than transfusing on the table (a core Patient Blood Management principle). Blood-component availability varies by centre, so plan cross-match/group-and-save early, activate the local massive transfusion protocol promptly in haemorrhage, and use tranexamic acid (cheap, effective) early in trauma and obstetric bleeding.
How Much, and Guided by What
2. Minimise blood loss โ surgical haemostasis, tranexamic acid, cell salvage, point-of-care coagulation testing (TEG/ROTEM), maintain normothermia & normal calcium/pH.
3. Optimise tolerance of anaemia โ restrictive triggers, single-unit transfusions, physiological support. The best transfusion is often the one you prevent.
Major Haemorrhage & Its Hazards
- Definition: ~10 units RBC in 24 h, or replacement of one blood volume, or major ongoing haemorrhage.
- Empirical ratio ~1:1:1 (RBC : FFP : platelets) until laboratory/viscoelastic results guide targeted therapy; give tranexamic acid early.
- Maintain the "lethal triad" defences: prevent hypothermia (warm fluids/patient), acidosis, and coagulopathy; give calcium (citrate in stored blood chelates it โ ionised hypocalcaemia).
- Targets: fibrinogen >1.5โ2 g/L, platelets >50 (>100 if CNS injury), normal ionised calcium, temperature >36 ยฐC.
- Acute haemolytic (ABO incompatibility) โ fever, loin/chest pain, hypotension, haemoglobinuria, DIC; stop immediately, resuscitate, check the unit/identity. Usually a clerical/identification error.
- Febrile non-haemolytic โ common, benign; slow/stop, antipyretic, exclude haemolysis.
- Allergic / anaphylaxis โ urticaria โ airway/circulatory collapse (esp. IgA deficiency); stop, treat as anaphylaxis.
- TACO (circulatory overload) โ hypertension, raised JVP, pulmonary oedema โ diuretics, slow rate. TRALI โ non-cardiogenic pulmonary oedema within 6 h, normal filling pressures โ supportive/ventilatory care.
- Delayed: delayed haemolysis, infection, iron overload, TA-GvHD (irradiated components for at-risk patients).
A Practical Flowchart
Assess the starting point
- Fasting deficit, ongoing losses, comorbidity (cardiac/renal), expected blood loss
- Optimise anaemia pre-operatively; group & save / cross-match appropriately
Maintenance & replacement
- Balanced crystalloid for maintenance (4-2-1) and to replace evaporative/third-space losses
- Avoid large-volume 0.9% saline; 5% dextrose is not for volume
Resuscitate to physiology
- Small boluses guided by fluid responsiveness (SVV/PPV, stroke-volume optimisation), not fixed volumes
- Aim for euvolaemia / zero balance in major surgery
Bleeding โ components + TXA
- Restrictive RBC trigger (Hb <70, or <80 if cardiac/symptomatic); single-unit & reassess
- Major haemorrhage โ activate MTP (~1:1:1), give TXA early, correct Caยฒโบ/temperature/pH
Reassess & de-escalate
- Guide ongoing therapy with lab/viscoelastic tests; stop fluids once perfused
- Watch for overload (TACO), electrolyte & acidโbase disturbance
Common Mistakes in Fluids & Transfusion
It causes hyperchloraemic metabolic acidosis and more renal dysfunction than balanced solutions. Use a balanced crystalloid (Ringer's/Plasma-Lyte) as the default for resuscitation and replacement.
Hydroxyethyl starches increase AKI and mortality in the critically ill (6S, CHEST) and are regulator-restricted. Colloids don't improve survival over crystalloids โ avoid HES.
Fluid overload causes oedema, anastomotic breakdown, ileus and respiratory failure. Target euvolaemia/zero balance and stop fluids once the patient is perfused.
Restrictive triggers (Hb <70, or <80 with cardiac disease) are as safe or safer. Transfuse a single unit and reassess; treat the cause of anaemia.
Hypothermia, acidosis and coagulopathy (plus ionised hypocalcaemia from citrate) perpetuate bleeding. Warm everything, give calcium, and correct pH โ not just more red cells.
TXA saves lives in trauma and PPH but only when given early (<3 h). Give it promptly โ it is cheap and widely available.
Acute haemolytic reactions are almost always ABO mismatches from mis-identification. Rigorous patient/sample/unit checking at the bedside prevents the most lethal transfusion hazard.
Exam Pearls
Q: State the 4-2-1 maintenance rule.
4 mL/kg/h for the first 10 kg + 2 mL/kg/h for the next 10 kg + 1 mL/kg/h for each kg above 20 (e.g. 70 kg โ 110 mL/h).
Q: How much crystalloid replaces 1 mL of blood loss?
~3โ4 mL of isotonic crystalloid (it distributes across the extracellular space, so only ~โ
stays intravascular). Blood or colloid replaces roughly 1:1.
Q: Balanced crystalloid vs 0.9% saline โ why prefer balanced?
Large-volume saline causes hyperchloraemic metabolic acidosis and more AKI; balanced solutions (Ringer's/Plasma-Lyte) are more physiological and are the default.
Q: What did SAFE and the starch trials show?
SAFE: albumin โ saline overall but worse in TBI. 6S/CHEST: hydroxyethyl starch causes more AKI and death in the critically ill โ avoid synthetic colloids.
Q: Restrictive transfusion trigger?
Transfuse at Hb <70 g/L (target 70โ90); use <80 g/L for symptomatic patients or cardiovascular disease/ACS. Single-unit transfusions with reassessment.
Q: Outline a massive transfusion protocol.
Empirical ~1:1:1 RBC:FFP:platelets, early tranexamic acid, correct hypothermia/acidosis/hypocalcaemia (citrate), targets: fibrinogen >1.5โ2 g/L, platelets >50 (>100 CNS), then switch to lab/viscoelastic-guided therapy.
Q: TACO vs TRALI?
TACO = circulatory overload โ hypertension, raised JVP, cardiogenic pulmonary oedema โ diuresis/slow rate. TRALI = immune non-cardiogenic pulmonary oedema within 6 h with normal filling pressures โ supportive/ventilatory care.
Q: Most lethal transfusion reaction and its cause?
Acute haemolytic reaction from ABO incompatibility โ almost always a bedside identification/clerical error. Stop immediately, resuscitate, and recheck identity and the unit.
References
- Gropper MA, et al. (eds). Miller's Anesthesia, 9th Edition. Perioperative Fluid & Electrolyte Therapy; Patient Blood Management. Elsevier; 2020.
- National Institute for Health and Care Excellence. Intravenous fluid therapy in adults in hospital (CG174); Blood transfusion (NG24). NICE.
- Finfer S, Bellomo R, Boyce N, et al. (SAFE Study). A comparison of albumin and saline for fluid resuscitation in the ICU. N Engl J Med. 2004;350:2247โ2256.
- Myburgh JA, Finfer S, Bellomo R, et al. (CHEST). Hydroxyethyl starch or saline for fluid resuscitation in intensive care. N Engl J Med. 2012;367:1901โ1911.
- Hรฉbert PC, Wells G, Blajchman MA, et al. (TRICC). A multicentre, randomised, controlled clinical trial of transfusion requirements in critical care. N Engl J Med. 1999;340:409โ417.
- CRASH-2 Collaborators. Effects of tranexamic acid on death, vascular events and transfusion in trauma patients. Lancet. 2010;376:23โ32.
- WOMAN Trial Collaborators. Effect of early tranexamic acid in women with post-partum haemorrhage. Lancet. 2017;389:2105โ2116.
- Butterworth JF, Mackey DC, Wasnick JD. Morgan & Mikhail's Clinical Anesthesiology, 6th Edition. Fluid Management & Transfusion. McGraw-Hill; 2018.